GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,619,000 | +1128.0% | 104,279 | +553.5% | 0.01% | +600.0% |
| Q4 2020 | $1,842,000 | +16.3% | 15,957 | -2.0% | 0.00% | 0.0% |
| Q3 2020 | $1,584,000 | -17.7% | 16,278 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $1,925,000 | -3.4% | 15,685 | -31.1% | 0.00% | 0.0% |
| Q1 2020 | $1,992,000 | -33.8% | 22,751 | -20.9% | 0.00% | 0.0% |
| Q4 2019 | $3,008,000 | +11.6% | 28,759 | +22.7% | 0.00% | 0.0% |
| Q3 2019 | $2,695,000 | -13.9% | 23,439 | +29.1% | 0.00% | 0.0% |
| Q2 2019 | $3,129,000 | +16.1% | 18,151 | +13.5% | 0.00% | 0.0% |
| Q1 2019 | $2,695,000 | +96.1% | 15,992 | +13.4% | 0.00% | 0.0% |
| Q4 2018 | $1,374,000 | -44.0% | 14,106 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $2,452,000 | +50.6% | 14,193 | +21.7% | 0.00% | 0.0% |
| Q2 2018 | $1,628,000 | +103.5% | 11,667 | +64.4% | 0.00% | – |
| Q1 2018 | $800,000 | +10.8% | 7,096 | +29.9% | 0.00% | – |
| Q4 2017 | $722,000 | +22.0% | 5,464 | -6.3% | 0.00% | – |
| Q3 2017 | $592,000 | +39.6% | 5,829 | +37.5% | 0.00% | – |
| Q2 2017 | $424,000 | -16.9% | 4,240 | +0.4% | 0.00% | – |
| Q1 2017 | $510,000 | +11.6% | 4,222 | +3.1% | 0.00% | – |
| Q4 2016 | $457,000 | -17.1% | 4,094 | -1.5% | 0.00% | – |
| Q3 2016 | $551,000 | +35.4% | 4,155 | -6.6% | 0.00% | – |
| Q2 2016 | $407,000 | -48.7% | 4,448 | -59.6% | 0.00% | – |
| Q1 2016 | $794,000 | +146.6% | 11,016 | +137.9% | 0.00% | – |
| Q4 2015 | $322,000 | -0.6% | 4,631 | +30.7% | 0.00% | – |
| Q3 2015 | $324,000 | -67.0% | 3,544 | -55.6% | 0.00% | -100.0% |
| Q2 2015 | $981,000 | +200.0% | 7,985 | +122.7% | 0.00% | – |
| Q1 2015 | $327,000 | -27.8% | 3,585 | -46.5% | 0.00% | – |
| Q4 2014 | $453,000 | -46.6% | 6,695 | -36.2% | 0.00% | -100.0% |
| Q3 2014 | $849,000 | +25.0% | 10,500 | +66.0% | 0.00% | – |
| Q2 2014 | $679,000 | +178.3% | 6,324 | +53.7% | 0.00% | – |
| Q1 2014 | $244,000 | +1642.9% | 4,115 | +1110.3% | 0.00% | – |
| Q4 2013 | $14,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|